Methods: A retrospective combine prospective, 36 patients with previously untreated stage III - IVA nasopharyngeal carcinoma (NPC) received Gemcitabine-Cisplatin induction chemotherapy at Nghe An Oncology Hospital from 1/2020 to 3/2022.